Vertex Pharmaceuticals, Inc. (VRTX)
427.65
+3.29
(+0.78%)
USD |
NASDAQ |
May 06, 16:00
425.63
-2.02
(-0.47%)
Pre-Market: 08:26
Vertex Pharmaceuticals Cash from Investing (Quarterly) : -431.90M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -3.916B |
| Amgen, Inc. | -716.00M |
| Biogen, Inc. | -209.50M |
| Gilead Sciences, Inc. | -1.835B |
| Moderna, Inc. | -76.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.428B |
| Cash from Financing (Quarterly) | -538.80M |
| Free Cash Flow | 3.710B |
| Free Cash Flow Per Share (Quarterly) | 5.052 |
| Free Cash Flow to Equity (Quarterly) | 1.344B |
| Free Cash Flow to Firm (Quarterly) | 1.295B |
| Free Cash Flow Yield | 3.37% |